| Scott Hammer, MD will be responsible for the supervision and coordination of the clinical infectious
disease training at Columbia University. Dr. Hammer is the Harold C. Neu Professor of Medicine, Professor of Public Health
(Epidemiology) and Chief of the Division of Infectious Diseases at the Columbia Presbyterian Medical Center. He is a graduate
of the College of Physicians & Surgeons, completed Internal Medicine Residency at the Presbyterian Hospital and Stanford
University Hospital and served as Chief Medical Resident at the Presbyterian Hospital. He completed Infectious Disease
Fellowship training at the Massachusetts General Hospital before joining the faculty of the Deaconess Hospital (now the Beth
Israel Deaconess Medical Center) and Harvard Medical School in 1982. He rose to the rank of Associate Professor of Medicine
at Harvard Medical School and Director of the Research Virology Laboratory at the Beth Israel Deaconess Medical Center before
being recruited back to Columbia in January 1999. Dr. Hammer's career has been devoted to improving the treatment of HIV
infection. He in an investigator in the National Institutes of Health sponsored AIDS Clinical Trials Group, a multicenter
organization which performs clinical trials designed to improve our understanding and treatment of HIV infection and its
complications.
|
|
As an AIDS Clinical Trials Group investigator, Dr. Hammer chaired the two largest national trials
of antiretroviral therapy carried out by that group in the 1990's, studies which contributed to the current standard of care
of HIV infection. In addition to his interest in the treatment of persons with established HIV infection, Dr. Hammer is an
investigator in the National Institutes of Health sponsored HIV Vaccine Trials Network, a multicenter organization whose mission
is to develop an effective preventive HIV vaccine. He is a former Chair of the Antiviral Products Advisory Committee of the Food
and Drug Administration and currently chairs the HIV Disease Research Agenda Committee of the AIDS Clinical Trials Group. On the
international level, he is a member of the Governing Council of the International AIDS Society and a member of the International
Advisory Committees of the Swiss HIV Cohort Study and the French National Association for AIDS Research.
|
